$INVA

Innoviva, Inc.

Nasdaq · Healthcare · Pharmaceutical Preparations · Burlingame, CA

INVA chart

What traders are saying about $INVA

Latest posts

Innoviva, Inc. news

Innoviva, Inc. key financials

USD2025202420232022
Revenue$411.3M$358.7M$310.5M$331.3M
Diluted EPS$3.30$0.36$2.20$2.37
Total assets (year end)$1.64B$1.30B$1.24B$1.23B
Cash and equivalents (year end)$550.9M$305.0M$193.5M$291.0M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Innoviva, Inc.

Ticker
INVA (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Burlingame, CA
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1080014
Former names
THERAVANCE INC, ADVANCED MEDICINE INC

Frequently asked questions

What exchange is Innoviva, Inc. listed on?

Innoviva, Inc. trades on the Nasdaq under the ticker symbol INVA.

What industry is Innoviva, Inc. in?

Innoviva, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Innoviva, Inc. headquartered?

Innoviva, Inc.'s business address on file with the SEC is in Burlingame, CA.

When does Innoviva, Inc.'s fiscal year end?

Innoviva, Inc.'s fiscal year ends on December 31.

How much revenue did Innoviva, Inc. report?

Innoviva, Inc. reported $411.3M in revenue for calendar year 2025, according to its SEC filings.